CAN-med Healthcare, a division of IMP Group Limited, announces an exclusive distribution agreement to distribute SANUWAVE's dermaPACE® device throughout Canada. Headquartered in Bedford, Nova Scotia, CAN-med Healthare will initially promote dermaPACE to heal diabetic foot ulcers (DFUs). The dermaPACE regenerative medicine device is a safe, cost-effective, noninvasive and easily administered wound closure modality that uses pulsed acoustic pressure waves (shock waves) to stimulate biologic effects at the molecular, cellular and tissue levels to positively modulate microvascular and inflammatory processes, ultimately leading to wound healing. Read more» |
As engaged corporate citizens, CAN-med Healthcare, our employees and our parent company, I.M.P. Group, are committed to giving back and making a difference in the vibrant communities in which we live and work. Read more » |
|